Table 4.

Quality of BD app information: concordance to BD treatment guidelines.

Statement	Apps covering topic, n (%)
1. Initiation of an atypical antipsychotic and/or mood stabilizer for the treatment of acute mania.	3 (16)
2. The use of an atypical antipsychotic or mood stabilizer, with or without an antidepressant, for the treatment of bipolar depression.	2 (11)
3. Antidepressant subtypes tricyclic antidepressants and SNRIs are more likely to cause switching than SSRIs.	0 (0)
4. Lithium, an atypical antipsychotic, or lamotrigine (where depression predominates) for maintenance treatment of BD.	4 (21)
5. Change monotherapy or use combination therapy for treatment resistance.	1 (5)
6. The use of ECT for treatment resistant acute symptoms (particularly depression, but also mania).	9 (47)
7. Careful monitoring of blood levels is required where those correlate with treatment response (eg, lithium, valproate).	2 (11)
8. Careful monitoring of potential physical complications or side effects of treatments is required (eg, kidney, thyroid, and calcium with lithium; glucose and lipids with antipsychotics).	1 (5)
9. Women informed about ensuring that their medications are safe to take during breastfeeding and pregnancy.	1 (5)
10. Seek medical professional advice and/or a second opinion in diagnosis of BD in children, due to the controversy in this area.	1 (5)
11. Outlines difficulties in the treatment of rapid cycling BD.	1 (5)
12. Optimal treatment for most patients with BD will include psychological treatment as well as medication.	10 (53)
13. Most patients benefit considerably from treatment for their BD.	10 (53)